Performance
Trailing returns
| 1 day |
| -1.46% | |||
| 1 week |
| -0.62% | |||
| 4 week | +4.55% |
| |||
| 3 month | +5.39% |
| |||
| YTD | +6.79% |
| |||
| 1 year | +32.10% |
| |||
| 3 years* | +11.12% |
| |||
| 5 years* |
| -0.38% | |||
| *annualised | |||||
| Best 3-month return | +34.19% | |
| Worst 3-month return | -33.57% |
Morningstar statistics
Morningstar category: Foreign Large Value
| Return | Risk | Rating | |
| 3 years | Average | Average |
 
|
| 5 years | Above Average | Average |
|
| 10 years | Above Average | Average |
|
| Overall | Above Average | Average |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 6,047.26M | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 0.80% | |
| Management fee | - | |
| Fund family | Franklin Templeton Investment Funds |
Asset allocation
| Cash | 3.15% | |
| Stocks | 96.85% | |
| Bonds | 0.00% | |
| Other | 0.00% |
Purchase information
| Initial | $0 |
20.87-0.06(-0.29%)
May 24, 4:00pm GMT-4
Overall Morningstar RatingTM
Description
The investment seeks long-term capital growth. The fund invests at least 80% of its net assets in foreign (non-U.S.) equity securities. It also invests in depositary receipts, as well as companies located in emerging markets countries. Depositary receipts are certificates typically issued by a bank or trust company that give their holders the right to receive securities issued by a foreign or domestic company. The equity securities in which the fund primarily invests are common stock. From time to time, based on economic conditions, the fund may have significant investments in one or more countries or in particular sectors.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
Cindy Sweeting (Started: Jan 1, 2001)
Peter Nori (Started: Dec 31, 1999)
Antonio Docal (Started: Dec 31, 2003)
Cindy Sweeting (Started: Jan 1, 2001)
Peter Nori (Started: Dec 31, 1999)
Antonio Docal (Started: Dec 31, 2003)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | -1.58 | -1.10 | 0.33 | 1.21 | |
| Beta* | 0.96 | 1.00 | 1.00 | 1.00 | |
| Mean annual return | 1.39 | 0.67 | 0.18 | 0.98 | |
| R-squared* | 95.49 | 96.86 | 97.00 | 96.05 | |
| Standard deviation | 15.87 | 19.89 | 23.48 | 18.52 | |
| Sharpe ratio | 1.05 | 0.40 | 0.08 | 0.54 | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Sanofi (SAN) | 2.77% | |
| Samsung Electronics Co Ltd (SSNLF) | 2.58% | |
| Telenor ASA (TEL) | 2.27% | |
| Roche Holding AG (RHHVF) | 2.24% | |
| GlaxoSmithKline PLC (GLAXF) | 2.21% | |
| Bayer AG (BAYN) | 1.95% | |
| DBS Group Holdings Ltd (D05) | 1.84% | |
| Vodafone Group PLC (VODPF) | 1.83% | |
| Merck KGaA (MRK) | 1.78% | |
| Swiss Re AG (SREN) | 1.76% |